Health Care & Life Sciences » Biotechnology | AEterna Zentaris Inc.

AEterna Zentaris Inc. | Cash Flow

Fiscal year is January-December. All values CAD Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
28,067.80
18,982.30
64,260.50
33,068.70
21,801.40
5,427
Depreciation, Depletion & Amortization
977.80
766.50
346.70
371.00
122.00
75.20
Other Funds
-
-
11,039.70
-
-
969.50
Funds from Operations
12,998.40
32,260.00
38,955.70
37,026.30
26,870.10
9,041.90
Changes in Working Capital
7,592.90
2,068.60
4,343.50
1,409.70
2,871.20
195.70
Net Operating Cash Flow
20,591.30
34,328.70
43,299.20
38,436.00
29,741.30
8,846.20
Capital Expenditures
87.60
140.30
33.30
87.40
5.20
Sale of Fixed Assets & Businesses
-
72.90
646.10
2.70
209.00
Purchase/Sale of Investments
-
-
555.20
331.20
194.70
Net Investing Cash Flow
28.90
67.40
1,168.10
416.00
398.50
Net Financing Cash Flow
24,428.50
26,902.30
52,196.00
13,148.50
10,423.00
Net Change in Cash
3,792.90
9,134.90
8,340.30
25,771.10
18,456.40
Free Cash Flow
20,678.90
34,468.90
43,332.50
38,523.40
29,746.50
Deferred Taxes & Investment Tax Credit
-
-
-
-
4,515.80
4,509.30
Other Sources
116.40
-
-
-
-
Change in Capital Stock
24,428.50
26,902.30
63,235.70
13,148.50
10,423.00
Exchange Rate Effect
73.20
1,641.20
1,724.60
67.60
463.40

About AEterna Zentaris

View Profile
Address
315 Sigma Drive
Charleston South Carolina 29486
United States
Employees -
Website http://www.aezsinc.com
Updated 07/08/2019
Æterna Zentaris, Inc. operates as a specialty biopharmaceutical company that is engaged in developing and commercializing novel treatments in oncology, endocrinology and women's health. It operates through biopharmaceutical segment. AEterna Zentaris was founded on September 12, 1990 and is headquartered in Charleston, SC.